Elevated levels of mutant p53 protein can serve as a biomarker for certain types of cancer. Additionally, the presence of p53 mutations can sometimes be used to predict a patient's response to specific treatments, such as chemotherapy. Research continues to identify additional biomarkers and develop more precise methods for detecting p53 mutations in clinical settings.
